Inventor · disambiguated record
Jonathan Lebowitz
Also filed as: LEBOWITZ JONATHAN · LEBOWITZ JONATHAN H
26 granted patents·20 pending applications·753 citations·filing 1995–2025
97Inventor score
Files withBIOMARIN PHARM INC23ZYSTOR THERAPEUTICS INC9LEBOWITZ JONATHAN6BALTIMORE DAVID1HARVARD COLLEGE1
Top patents by PatentIndex Score
46 records- 0197US7981864B2Methods and compositions for targeting proteins across the blood brain barrierBIOMARIN PHARM INC·Filed 2008·Granted Jul 19, 2011·23 cites·8 claims
- 0297US7858576B2Method for targeting lysosomal enzymesZYSTOR THERAPEUTICS INC·Filed 2007·Granted Dec 28, 2010·36 cites·15 claims
- 0397US7560424B2Targeted therapeutic proteinsZYSTOR THERAPEUTICS INC·Filed 2002·Granted Jul 14, 2009·70 cites·33 claims
- 0496US7396811B2Subcellular targeting of therapeutic proteinsZYSTOR THERAPEUTICS INC·Filed 2002·Granted Jul 8, 2008·90 cites·14 claims
- 0594US9834587B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·6 cites·12 claims
- 0694US9834588B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·7 cites·12 claims
- 0794US9814762B2Targeted therapeutic proteinsBIOMARIN PHARM INC·Filed 2016·Granted Nov 14, 2017·6 cites·24 claims
- 0894US8492337B2Targeted therapeutic proteinsLEBOWITZ JONATHAN·Filed 2011·Granted Jul 23, 2013·10 cites·29 claims
- 0994US7785856B2Acid alpha-glucosidase and fragments thereofZYSTOR THERAPEUTICS INC·Filed 2007·Granted Aug 31, 2010·51 cites·3 claims
- 1094US7629309B2Targeted therapeutic proteinsZYSTOR THERAPEUTICS INC·Filed 2004·Granted Dec 8, 2009·42 cites·27 claims
- 1193US10301369B2Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteinsBIOMARIN PHARM INC·Filed 2017·Granted May 28, 2019·5 cites·17 claims
- 1293US8785168B2Formulations for lysosomal enzymesLEBOWITZ JONATHAN·Filed 2010·Granted Jul 22, 2014·30 cites·21 claims
- 1392US10300113B2Targeted therapeutic proteinsBIOMARIN PHARM INC·Filed 2017·Granted May 28, 2019·3 cites·17 claims
- 1492US9771408B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Sep 26, 2017·4 cites·12 claims
- 1591US11351231B2Lysosomal targeting peptides and uses thereofBIOMARIN PHARM INC·Filed 2017·Granted Jun 7, 2022·3 cites·7 claims
- 1691US9845346B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 19, 2017·4 cites·12 claims
- 1791US9469683B2Lysosomal targeting peptides and uses thereofBIOMARIN PHARM INC·Filed 2014·Granted Oct 18, 2016·12 cites·5 claims
- 1891US9376480B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2013·Granted Jun 28, 2016·6 cites·21 claims
- 1991US6410516B1Nuclear factors associated with transcriptional regulationHARVARD COLLEGE·Filed 1995·Granted Jun 25, 2002·167 cites·203 claims
- 2090US11254725B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2019·Granted Feb 22, 2022·2 cites·13 claims
- 2189US8859498B2Targeted therapeutic proteinsBIOMARIN PHARM INC·Filed 2013·Granted Oct 14, 2014·3 cites·20 claims
- 2288US8563691B2Lysosomal targeting peptides and uses thereofLEBOWITZ JONATHAN·Filed 2012·Granted Oct 22, 2013·10 cites·21 claims
- 2387US6150090ANuclear factors associated with transcriptional regulationMASSACHUSETTS INST TECHNOLOGY·Filed 1995·Granted Nov 21, 2000·69 cites·24 claims
- 2486US8492338B2Targeted therapeutic proteinsLEBOWITZ JONATHAN·Filed 2012·Granted Jul 23, 2013·5 cites·17 claims
- 2586US8207114B2Targeted therapeutic proteinsLEBOWITZ JONATHAN H·Filed 2009·Granted Jun 26, 2012·7 cites·3 claims
- 2683US5804374ANuclear factors associates with transcriptional regulationMASSACHUSETTS INSTI TECHNOLOGY·Filed 1995·Granted Sep 8, 1998·82 cites·5 claims
- 2781US2023241187A1Lysosomal Targeting Peptides and Uses ThereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 2881US2022354934A1Lysosomal Targeting Peptides and Uses ThereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 2980US2022127326A1Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses ThereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 3077US2025388644A1Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 3176US2019224282A1Targeted Therapeutic ProteinsBIOMARIN PHARM INC·Filed 2019·Application pending·0 cites
- 3274US2015064183A1Targeted therapeutic proteinsBIOMARIN PHARM INC·Filed 2014·Application pending·0 cites
- 3372US2021069304A1Lysosomal Targeting Peptides and Uses ThereofBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 3471US2009203575A1Targeted therapeutic proteinsZYSTOR THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3567US2011223147A1Lysosomal targeting peptides and uses thereofZYSTOR THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3660US2017007680A1Lysosomal Targeting Peptides and Uses ThereofBIOMARIN PHARM INC·Filed 2016·Application pending·0 cites
- 3758US2003072761A1Methods and compositions for targeting proteins across the blood brain barrierFiled 2002·Application pending·0 cites
- 3858US2006063709A1Nuclear factors associated with transcriptional regulationBALTIMORE DAVID·Filed 2002·Application pending·0 cites
- 3956US2006121018A1Methods and compositions for targeting proteins across the blood brain barrierZYSTOR THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4055US2004214757A1Nuclear factors associated with transcriptional regulationFiled 2002·Application pending·0 cites
- 4154US2009117091A1Methods for treating pompe diseaseLEBOWITZ JONATHAN·Filed 2007·Application pending·0 cites
- 4249US2023192799A1CNP Variants and Conjugates ThereofBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 4348US2004005309A1Targeted therapeutic proteinsSYMBIONTICS INC·Filed 2002·Application pending·0 cites
- 4448US2022280647A1Hydrophobic Peptide Salts for Extended Release CompositionsBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 4548US2005244400A1Acid alpha-glucosidase and fragments thereofZYSTOR THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4645US2012093794A1Methods for Treating Pompe DiseaseLEBOWITZ JONATHAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Lebowitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →